Search for Clinical Trial Results
Mumps - 24 Studies Found
Status | Study |
Completed |
Study Name: Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases Condition:
Interventions: Biological: Measles, Mumps, Rubella and Chickenpox (live vaccine) |
Completed |
Study Name: Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases Condition:
Interventions: Biological: Measles, Mumps, Rubella and Chickenpox (live vaccine) Other Names: |
Completed |
Study Name: Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months. Condition:
Interventions: |
Completed |
Study Name: Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers Condition:
|
Completed |
Study Name: Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136 Condition:
Date: 2008-09-10 Interventions: |
Withdrawn |
Study Name: Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the Philippines Condition:
Interventions: |
Completed |
Study Name: Measles, Mumps, and Rubella (MMR) Immunity in College Students Condition:
Date: 2008-05-19 Interventions: Biological: MMR vaccine People with no antibodies to either mumps, measles and rubella will be offered t |
Completed |
Study Name: Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ Condition:
Interventions: |
Recruiting |
Study Name: Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella Vaccine Condition:
|
Completed |
Study Name: Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016) Condition:
Interventions: Biological: V221, measles, mumps, rubella and varicella (Oka/Merck) virus vaccine live / Duration of Treatment: 12 weeks |